ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 151 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $169,000 | -82.8% | 28,005 | -89.7% | 0.00% | -88.9% |
Q3 2019 | $981,000 | +178.7% | 272,465 | +107.7% | 0.01% | +200.0% |
Q2 2019 | $352,000 | +186.2% | 131,168 | +216.8% | 0.00% | +200.0% |
Q1 2019 | $123,000 | +48.2% | 41,407 | -20.9% | 0.00% | 0.0% |
Q4 2018 | $83,000 | -93.9% | 52,328 | -85.9% | 0.00% | -93.8% |
Q3 2018 | $1,368,000 | +117.1% | 371,657 | +66.9% | 0.02% | +100.0% |
Q2 2018 | $630,000 | -5.8% | 222,685 | -4.1% | 0.01% | -33.3% |
Q4 2017 | $669,000 | +208.3% | 232,146 | +381.1% | 0.01% | +200.0% |
Q3 2017 | $217,000 | -11.4% | 48,251 | -17.2% | 0.00% | -42.9% |
Q1 2017 | $245,000 | -61.2% | 58,268 | -61.9% | 0.01% | -73.1% |
Q4 2016 | $631,000 | +122.2% | 152,825 | +336.6% | 0.03% | +36.8% |
Q3 2016 | $284,000 | -35.5% | 35,000 | -37.9% | 0.02% | -29.6% |
Q2 2016 | $440,000 | +95.6% | 56,400 | +93.8% | 0.03% | +58.8% |
Q1 2016 | $225,000 | -70.5% | 29,100 | -58.9% | 0.02% | -79.8% |
Q4 2015 | $764,000 | – | 70,800 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |